CDKN2B and colorectal carcinoma: As presented in Figure 7D, PRMT5 (r2 = 0.3411, P < 0.01) and EZH2 (r2 = 0.2113, P < 0.01) were negatively correlated with CDKN2B expression in CRC samples, respectively.